{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T22:13:05Z","timestamp":1785363185438,"version":"3.55.0"},"reference-count":36,"publisher":"American Society of Hematology","issue":"20","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,10,28]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>Immune-mediated thrombotic thrombocytopenic purpura (iTTP) is a rare life-threatening thrombotic disorder, which results from the development of autoantibodies targeting ADAMTS13. Most patients (&amp;gt;90%) with iTTP display antibodies against a shared epitope in the spacer domain of ADAMTS13. Nevertheless, a smaller population of patients (20%-40%) also has antibodies directed toward the CUB (complement C1r\/C1s, Uegf, Bmp1) domains of ADAMTS13. Here, we explored whether anti-CUB antibodies have a shared epitope located on CUB domains of ADAMTS13 that overlaps with the spacer-CUB domain interface. Hydrogen-deuterium exchange mass spectrometry revealed that a panel of patient-derived human monoclonal anti\u2013CUB domain antibodies specifically targeted peptides 1248-1253 and 1359-1377 in the CUB1 and CUB2 domains, respectively. A parallel alanine screen showed that residues W1250, K1252, and R1367 are crucially involved in binding of anti\u2013CUB domain antibodies. A triple alanine variant containing W1250A\/K1252A\/R1367A ameliorated the binding of all patient-derived monoclonal antibodies. This triple-alanine variant also showed greatly reduced binding of anti-CUB antibodies upon analysis of plasma samples of a panel of 27 patients with iTTP. Functional analysis of the anti-CUB antibodies showed that all antibodies were able to induce an open conformation but did not inhibit activity toward either peptide substrates or von Willebrand factor multimers under flow conditions. Collectively, our findings show that anti-CUB antibodies target residues W1250\/K1252 and R1367. Binding of pathogenic antibodies disrupt the spacer-CUB domain interface, thereby inducing an open conformation in ADAMTS13.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1182\/bloodadvances.2025017193","type":"journal-article","created":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T17:39:25Z","timestamp":1754674765000},"page":"5350-5361","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":2,"title":["Trp1250, Lys1252, and Arg1367 of ADAMTS13 comprise a hot spot for anti-CUB domain antibodies in patients with iTTP"],"prefix":"10.1182","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1828-7957","authenticated-orcid":false,"given":"Tim","family":"Postmus","sequence":"first","affiliation":[{"name":"1Department of Molecular Hematology, Sanquin Research, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"Jansen","sequence":"additional","affiliation":[{"name":"1Department of Molecular Hematology, Sanquin Research, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Kaijen","sequence":"additional","affiliation":[{"name":"1Department of Molecular Hematology, Sanquin Research, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Floris","family":"van Alphen","sequence":"additional","affiliation":[{"name":"1Department of Molecular Hematology, Sanquin Research, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"van der Zwaan","sequence":"additional","affiliation":[{"name":"1Department of Molecular Hematology, Sanquin Research, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arie J.","family":"Hoogendijk","sequence":"additional","affiliation":[{"name":"1Department of Molecular Hematology, Sanquin Research, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Coppo","sequence":"additional","affiliation":[{"name":"2Department of Hematology, Service d'H\u00e9matologie Biologique and EA3518-Institut Universitaire d'H\u00e9matologie, Groupe Hospitalier Saint Louis-Lariboisi\u00e8re, Assistance Publique-H\u00f4pitaux de Paris, Universit\u00e9 Paris Diderot, Paris, France"},{"name":"3Department of Hematology, Centre National de R\u00e9f\u00e9rence des Microangiopathies Thrombotiques, H\u00f4pital Saint-Antoine, Assistance Publique-H\u00f4pitaux de Paris, Sorbonne Universit\u00e9, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0151-337X","authenticated-orcid":false,"given":"B\u00e9rang\u00e8re S.","family":"Joly","sequence":"additional","affiliation":[{"name":"3Department of Hematology, Centre National de R\u00e9f\u00e9rence des Microangiopathies Thrombotiques, H\u00f4pital Saint-Antoine, Assistance Publique-H\u00f4pitaux de Paris, Sorbonne Universit\u00e9, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agn\u00e8s","family":"Veyradier","sequence":"additional","affiliation":[{"name":"3Department of Hematology, Centre National de R\u00e9f\u00e9rence des Microangiopathies Thrombotiques, H\u00f4pital Saint-Antoine, Assistance Publique-H\u00f4pitaux de Paris, Sorbonne Universit\u00e9, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2288-8277","authenticated-orcid":false,"given":"Karen","family":"Vanhoorelbeke","sequence":"additional","affiliation":[{"name":"4Laboratory for Thrombosis Research, Interdisciplinary Research Facility Life Sciences, Katholieke Universiteit Leuven Campus Kulak Kortrijk, Kortrijk, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2482-0412","authenticated-orcid":false,"given":"Gerry","family":"Nicolaes","sequence":"additional","affiliation":[{"name":"5Department of Biochemistry, Cardiovascular Research Institute Maastricht, Maastricht University, Maastricht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4585-2621","authenticated-orcid":false,"given":"Jan","family":"Voorberg","sequence":"additional","affiliation":[{"name":"1Department of Molecular Hematology, Sanquin Research, Amsterdam, The Netherlands"},{"name":"6Department of Experimental Vascular Medicine, Amsterdam University Medical Centre, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2025,10,20]]},"reference":[{"issue":"3","key":"2025102810265039600_bib1","doi-asserted-by":"crossref","first-page":"536","DOI":"10.3390\/jcm10030536","article-title":"Thrombotic thrombocytopenic purpura: pathophysiology, diagnosis, and management","volume":"10","author":"Sukumar","year":"2021","journal-title":"J Clin Med"},{"issue":"8","key":"2025102810265039600_bib2","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/j.ebiom.2015.06.007","article-title":"Pathogenicity of anti-ADAMTS13 autoantibodies in acquired thrombotic thrombocytopenic purpura","volume":"2","author":"Thomas","year":"2015","journal-title":"EBioMedicine"},{"issue":"11","key":"2025102810265039600_bib3","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.3324\/haematol.2010.036327","article-title":"Residues Arg568 and Phe592 contribute to an antigenic surface for anti-ADAMTS13 antibodies in the spacer domain","volume":"96","author":"Pos","year":"2011","journal-title":"Haematologica"},{"issue":"9","key":"2025102810265039600_bib4","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.3324\/haematol.2009.019299","article-title":"Multiple domains of ADAMTS13 are targeted by autoantibodies against ADAMTS13 in patients with acquired idiopathic thrombotic thrombocytopenic purpura","volume":"95","author":"Zheng","year":"2010","journal-title":"Haematologica"},{"key":"2025102810265039600_bib5","doi-asserted-by":"crossref","first-page":"17020","DOI":"10.1038\/nrdp.2017.20","article-title":"Thrombotic thrombocytopenic purpura","volume":"3","author":"Kremer Hovinga","year":"2017","journal-title":"Nat Rev Dis Primers"},{"issue":"22","key":"2025102810265039600_bib6","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1056\/NEJM199811263392203","article-title":"Antibodies to von Willebrand factor\u2013cleaving protease in acute thrombotic thrombocytopenic purpura","volume":"339","author":"Tsai","year":"1998","journal-title":"N Engl J Med"},{"issue":"8","key":"2025102810265039600_bib7","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1182\/blood-2009-06-229203","article-title":"An autoantibody epitope comprising residues R660, Y661, and Y665 in the ADAMTS13 spacer domain identifies a binding site for the A2 domain of VWF","volume":"115","author":"Pos","year":"2010","journal-title":"Blood"},{"issue":"02","key":"2025102810265039600_bib8","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1160\/TH04-05-0301","article-title":"The spacer domain of ADAMTS13 contains a major binding site for antibodies in patients with thrombotic thrombocytopenic purpura","volume":"93","author":"Luken","year":"2005","journal-title":"Thromb Haemost"},{"issue":"11","key":"2025102810265039600_bib9","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.3324\/haematol.2019.226068","article-title":"Modifying ADAMTS13 to modulate binding of pathogenic autoantibodies of patients with acquired thrombotic thrombocytopenic purpura","volume":"105","author":"Gra\u00e7a","year":"2020","journal-title":"Haematologica"},{"issue":"17","key":"2025102810265039600_bib10","doi-asserted-by":"crossref","first-page":"3427","DOI":"10.1182\/bloodadvances.2020004172","article-title":"Anti-ADAMTS13 autoantibody profiling in patients with immune-mediated thrombotic thrombocytopenic purpura","volume":"5","author":"Kangro","year":"2021","journal-title":"Blood Adv"},{"issue":"12","key":"2025102810265039600_bib11","doi-asserted-by":"crossref","first-page":"4514","DOI":"10.1182\/blood-2003-12-4165","article-title":"Epitope mapping of ADAMTS13 autoantibodies in acquired thrombotic thrombocytopenic purpura","volume":"103","author":"Klaus","year":"2004","journal-title":"Blood"},{"issue":"9","key":"2025102810265039600_bib12","doi-asserted-by":"crossref","first-page":"3241","DOI":"10.1182\/blood-2003-05-1616","article-title":"Nonneutralizing IgM and IgG antibodies to von Willebrand factor-cleaving protease (ADAMTS-13) in a patient with thrombotic thrombocytopenic purpura","volume":"102","author":"Scheiflinger","year":"2003","journal-title":"Blood"},{"issue":"6","key":"2025102810265039600_bib13","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1016\/j.jtha.2023.02.011","article-title":"Autoantibodies enhance ADAMTS-13 clearance in patients with immune thrombotic thrombocytopenic purpura","volume":"21","author":"Underwood","year":"2023","journal-title":"J Thromb Haemost"},{"issue":"21","key":"2025102810265039600_bib14","doi-asserted-by":"crossref","first-page":"4480","DOI":"10.1182\/bloodadvances.2021004971","article-title":"Anti-cysteine\/spacer antibodies that open ADAMTS13 are a common feature in iTTP","volume":"5","author":"De Waele","year":"2021","journal-title":"Blood Adv"},{"issue":"11","key":"2025102810265039600_bib15","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1111\/jth.13149","article-title":"Linker regions and flexibility around the metalloprotease domain account for conformational activation of ADAMTS-13","volume":"13","author":"Deforche","year":"2015","journal-title":"J Thromb Haemost"},{"issue":"2","key":"2025102810265039600_bib16","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/jth.13922","article-title":"An open conformation of ADAMTS-13 is a hallmark of acute acquired thrombotic thrombocytopenic purpura","volume":"16","author":"Roose","year":"2018","journal-title":"J Thromb Haemost"},{"issue":"6","key":"2025102810265039600_bib17","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1182\/bloodadvances.2019001375","article-title":"Antibodies that conformationally activate ADAMTS13 allosterically enhance metalloprotease domain function","volume":"4","author":"Schelpe","year":"2020","journal-title":"Blood Adv"},{"issue":"3","key":"2025102810265039600_bib18","first-page":"353","article-title":"Open ADAMTS13, induced by antibodies, is a biomarker for subclinical immune-mediated thrombotic thrombocytopenic purpura","volume":"136","author":"Roose","year":"2020","journal-title":"Blood"},{"issue":"7","key":"2025102810265039600_bib19","doi-asserted-by":"crossref","first-page":"102603","DOI":"10.1016\/j.rpth.2024.102603","article-title":"Mechanistic insight into multiple antibody binding to ADAMTS13 in immune thrombotic thrombocytopenic purpura","volume":"8","author":"Halkidis","year":"2024","journal-title":"Res Pract Thromb Haemost"},{"issue":"8","key":"2025102810265039600_bib20","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1182\/bloodadvances.2024014950","article-title":"Unraveling antibody-induced structural dynamics in the ADAMTS13 CUB1-2 domains via HDX-MS","volume":"9","author":"Bonnez","year":"2025","journal-title":"Blood Adv"},{"issue":"16","key":"2025102810265039600_bib21","doi-asserted-by":"crossref","first-page":"eabg4403","DOI":"10.1126\/sciadv.abg4403","article-title":"Crystal structure of ADAMTS13 CUB domains reveals their role in global latency","volume":"7","author":"Kim","year":"2021","journal-title":"Sci Adv"},{"issue":"7","key":"2025102810265039600_bib22","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1111\/trf.13584","article-title":"ADAMTS13 autoantibodies cloned from patients with acquired thrombotic thrombocytopenic purpura: 1. Structural and functional characterization in vitro","volume":"56","author":"Ostertag","year":"2016","journal-title":"Transfusion (Paris)"},{"issue":"7","key":"2025102810265039600_bib23","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1111\/trf.13583","article-title":"ADAMTS13 autoantibodies cloned from patients with acquired thrombotic thrombocytopenic purpura: 2. Pathogenicity in an animal model","volume":"56","author":"Ostertag","year":"2016","journal-title":"Transfusion (Paris)"},{"issue":"5","key":"2025102810265039600_bib24","doi-asserted-by":"crossref","first-page":"e237","DOI":"10.1016\/S2352-3026(16)30018-7","article-title":"Epidemiology and pathophysiology of adulthood-onset thrombotic microangiopathy with severe ADAMTS13 deficiency (thrombotic thrombocytopenic purpura): a cross-sectional analysis of the French national registry for thrombotic microangiopathy","volume":"3","author":"Mariotte","year":"2016","journal-title":"Lancet Haematol"},{"issue":"7","key":"2025102810265039600_bib25","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1182\/bloodadvances.2024014298","article-title":"N-glycan shielded CUB domains of ADAMTS13 prevent binding of C-terminal antibodies in patients with immune-mediated TTP","volume":"9","author":"Postmus","year":"2025","journal-title":"Blood Adv"},{"issue":"12","key":"2025102810265039600_bib26","doi-asserted-by":"crossref","first-page":"3402","DOI":"10.1016\/j.jtha.2023.08.017","article-title":"Impact of N-glycan mediated shielding of ADAMTS-13 on the binding of pathogenic antibodies in immune thrombotic thrombocytopenic purpura","volume":"21","author":"Postmus","year":"2023","journal-title":"J Thromb Haemost"},{"issue":"19","key":"2025102810265039600_bib27","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1182\/blood.2020007972","article-title":"N-glycan\u2013mediated shielding of ADAMTS13 prevents binding of pathogenic autoantibodies in immune-mediated TTP","volume":"137","author":"Ercig","year":"2021","journal-title":"Blood"},{"issue":"12","key":"2025102810265039600_bib28","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1182\/blood-2010-04-280479","article-title":"Thrombotic thrombocytopenic purpura directly linked with ADAMTS13 inhibition in the baboon (Papio ursinus)","volume":"116","author":"Feys","year":"2010","journal-title":"Blood"},{"issue":"52","key":"2025102810265039600_bib29","doi-asserted-by":"crossref","first-page":"18578","DOI":"10.1073\/pnas.1411979112","article-title":"Conformational activation of ADAMTS13","volume":"111","author":"South","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"2025102810265039600_bib30","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1160\/th14-02-0148","article-title":"Antibody-based prevention of von Willebrand factor degradation mediated by circulatory assist devices","volume":"112","author":"Rauch","year":"2014","journal-title":"Thromb Haemost"},{"issue":"12","key":"2025102810265039600_bib31","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1111\/j.1538-7836.2009.03620.x","article-title":"Multi-step binding of ADAMTS-13 to von Willebrand factor","volume":"7","author":"Feys","year":"2009","journal-title":"J Thromb Haemost"},{"issue":"13","key":"2025102810265039600_bib32","doi-asserted-by":"crossref","first-page":"2819","DOI":"10.1182\/blood-2009-05-224915","article-title":"A novel binding site for ADAMTS13 constitutively exposed on the surface of globular VWF","volume":"114","author":"Zanardelli","year":"2009","journal-title":"Blood"},{"issue":"16","key":"2025102810265039600_bib33","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1091\/mbc.E19-01-0021","article-title":"Domain-specific mechanical modulation of VWF\u2013ADAMTS13 interaction","volume":"30","author":"Li","year":"2019","journal-title":"Mol Biol Cell"},{"issue":"6","key":"2025102810265039600_bib34","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1182\/blood-2007-04-083329","article-title":"The cooperative activity between the carboxyl-terminal TSP1 repeats and the CUB domains of ADAMTS13 is crucial for recognition of von Willebrand factor under flow","volume":"110","author":"Zhang","year":"2007","journal-title":"Blood"},{"issue":"13","key":"2025102810265039600_bib35","doi-asserted-by":"crossref","first-page":"4139","DOI":"10.1182\/blood-2005-05-2029","article-title":"Recombinant CUB-1 domain polypeptide inhibits the cleavage of ULVWF strings by ADAMTS13 under flow conditions","volume":"106","author":"Tao","year":"2005","journal-title":"Blood"},{"issue":"17","key":"2025102810265039600_bib36","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1182\/blood-2018-11-886309","article-title":"Exploring the \u2018minimal\u2019 structure of a functional ADAMTS13 by mutagenesis and small-angle X-ray scattering","volume":"133","author":"Zhu","year":"2019","journal-title":"Blood"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/9\/20\/5350\/2417693\/blooda_adv-2025-017193-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/9\/20\/5350\/2417693\/blooda_adv-2025-017193-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T14:32:01Z","timestamp":1761661921000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/9\/20\/5350\/546532\/Trp1250-Lys1252-and-Arg1367-of-ADAMTS13-comprise-a"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,20]]},"references-count":36,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2025,10,28]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2025017193","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,10,28]]},"published":{"date-parts":[[2025,10,20]]}}}